Net Sales decreased 2.1%, Organic
Net Sales decreased 1.3%
GAAP EPS decreased $0.13, Adjusted EPS
decreased $0.17, or flat at constant
currency
Updates Full Year Outlook to reflect Foreign
Currency Changes
SHELTON,
Conn., Feb. 10, 2025 /PRNewswire/ --
Edgewell Personal Care Company (NYSE: EPC) today announced
results for its first fiscal quarter 2025 ended December 31, 2024.
Executive Summary
- Net sales were $478.4 million, a
decrease of 2.1% compared to the prior year quarter.
- Organic net sales decreased 1.3% (Organic basis excludes the
impact from currency movements.)
- GAAP Diluted Net (Loss) Earnings Per Share ("EPS") were
$(0.04), compared to $0.09 in the prior year quarter.
- Adjusted EPS were $0.07,
inclusive of a $0.17 unfavorable
impact from currency movements, as compared to $0.24 in the prior year quarter.
- Ended the first quarter with $176
million in cash on hand, access to an additional
$221 million revolving credit
facility and a net debt leverage ratio of 3.8x.
- Returned $38 million to
shareholders in the form of $30
million in share repurchases and $8
million of dividends in the first quarter.
- The Board of Directors declared a cash dividend of $0.15 per common share on February 6, 2025 for the first quarter.
The Company reports and forecasts results on a GAAP and
non-GAAP basis and has reconciled non-GAAP results and outlook to
the most directly comparable GAAP measures later in this release.
See non-GAAP Financial Measures for a more detailed explanation,
including definitions of various non-GAAP terms used in this
release. All comparisons used in this release are for the same
period in the prior fiscal year unless otherwise
stated.
"We started the fiscal year with solid first quarter results
that were operationally as we expected. We saw continued top line
growth across our international markets and further momentum in our
Right to Win businesses, and we exceeded our gross margin
expectations, driven by further productivity savings. This resulted
in better than expected constant currency adjusted EBITDA and
earnings per share. Our performance continues to demonstrate
traction against our broader strategic priorities though the
strengthening US dollar significantly impacted our top and
bottom-line results for the quarter, and we expect further
additional headwinds for the year. As we look ahead, we will focus
on driving operational performance and executing in areas within
our control. We continue to expect to deliver organic net sales,
adjusted EBITDA and adjusted EPS within our previously provided
range, and the latter despite these greater than anticipated
foreign currency headwinds."
Fiscal 1Q 2025 Operating Results (Unaudited)
Net
sales were $478.4 million in
the quarter, a decrease of 2.1%, including a $4.0 million unfavorable impact from currency
movements. Organic net sales decreased 1.3%. Growth in
international markets was 2.0%, driven by both price and volume
gains, and seen across Wet Shave and Sun & Skin
Care. Organic sales declined in North America by 3.9%, due to declines in Wet
Shave and Feminine Care. Globally, by segment, growth in Sun
and Skin care, led by double-digit increases in Wet One's and
Grooming, was offset by declines in Feminine Care and Wet
Shave. In aggregate, organic net sales decreased as a result
of slightly lower volumes and lower price, due to increased
promotional levels.
Gross profit was $191.6
million, as compared to $197.7
million in the prior year quarter. Gross margin as a
percent of net sales decreased 30-basis points, to 40.1% in the
quarter, inclusive of approximately 140-basis points of negative
foreign currency. Adjusted gross margin, as a percent of net sales,
decreased 60-basis points, or increased 80-basis points at constant
currency. Productivity savings of approximately 340-basis
points were more than offset by increased promotional levels (net
of pricing) of approximately 40-basis points, core inflation and
lower volume absorption of approximately 200-basis points and
unfavorable mix and other of approximately 20-basis points.
Advertising and sales promotion expense ("A&P") was
$50.3 million, or 10.5% of net sales,
an increase of $2.1 million, compared
to $48.2 million, or 9.9%, of net
sales in the prior year quarter.
Selling, general and administrative expense
("SG&A") was $102.9
million, or 21.5% of net sales, as compared to $103.3 million, or 21.1% of net sales in the
prior year quarter. Adjusted SG&A was 21.2% of net sales, an
increase of 20-basis points, primarily driven by higher people and
consulting expenses and the impact of lower net sales, partially
offset by lower incentive compensation expense, lower bad debt and
favorable currency impacts.
The Company recorded pre-tax restructuring and re-positioning
expenses and costs in support of cost efficiency and effectiveness
programs of $4.2 million in the
quarter and acquisition and integration costs related to the Billie
acquisition of $0.5 million.
Operating income, was $20.3
million, or 4.2% of net sales, inclusive of a $7.8 million unfavorable currency movement,
compared to $26.1 million in the
prior year quarter. Adjusted operating income was $27.0 million, or 5.6% of net sales, compared to
$35.7 million, or 7.3% of net sales
in the prior year quarter.
Interest expense associated with debt was
$18.8 million, compared to
$19.8 million in the prior year
quarter. The decrease in interest expense was the result of a lower
overall debt balance on the Company's revolving credit
facility.
Other expense, net was $3.2
million compared to $0.3
million in the prior year quarter. Currency hedge and
remeasurements losses were $2.0
million in the current quarter, compared to gains of
$1.3 million in the prior year
quarter.
The effective tax rate for the first three months of
fiscal 2025 was (21.7)% compared to 20.1% in the prior year period.
The fiscal 2025 effective tax rate reflects the impact of net
unfavorable discrete items on a pretax (loss) and the unfavorable
mix of earnings in higher tax rate jurisdictions. The adjusted
effective tax rate for the first three months of fiscal 2025 was
43.6%, up from the prior year period adjusted effective tax rate of
22.8%.
GAAP net (loss) earnings were a loss of $2.1 million or $0.04 per diluted share
compared to earnings of $4.8 million
or $0.09 per diluted share in the
prior year quarter. Adjusted net earnings were $3.3 million or $0.07 per share, inclusive of a $0.17 unfavorable currency impact, compared to
$12.0 million or $0.24 per share in the prior year quarter.
Adjusted EBITDA was $45.9 million,
inclusive of a $11.2 million
unfavorable currency impact, compared to $57.2 million in the prior year
quarter.
Net cash used for operating activities was
$115.6 million for the three
months ending December 31, 2024, compared to $72.9 million in the prior year period. The
increase in cash used for operating activities was largely driven
by changes in net working capital and lower earnings.
Capital Allocation
On February 6, 2025, the
Board of Directors declared a quarterly cash dividend of
$0.15 per common share for the first
fiscal quarter of fiscal 2025. The dividend will be payable on
April 9, 2025 to shareholders of
record as the close of business on March 5,
2025. During the first quarter of fiscal 2025, the Company
paid dividends totaling $7.9 million
to stockholders and completed share repurchases of approximately
0.8 million shares at a total cost of $30.3
million. As of December 31,
2024, the Company had 2.2 million shares of common stock
available for repurchase in the future under the Board's 2018
authorization.
Fiscal 1Q 2025 Operating Segment Results (Unaudited)
Wet Shave (Men's Systems, Women's Systems, Disposables,
and Shave Preps)
Net sales a decrease $7.2 million,
or 2.4%. Organic net sales decreased $4.0
million or 1.3%, as growth in international markets, driven
by both higher volumes and price, was more than offset by volume
declines in Shave Preps and Women's Systems in North America. Wet Shave segment profit
decreased $7.1 million, or 13.2%.
Organic segment profit, excluding the unfavorable impact from
currency decreased $0.2 million, or
0.4%, as higher gross margins were primarily offset by higher
marketing and SG&A expenses.
Sun and Skin Care (Sun
Care, Wet Ones, Bulldog, Jack
Black and Cremo)
Net sales increased $5.2 million,
or 4.5%. Organic net sales increased $5.9
million, or 5.1%, driven by strong performance in Grooming,
led by Cremo and Billie, as well as Wet One's, partly offset by
declines in North America Sun Care. Organic segment profit
decreased $2.1 million, or 161.5%,
with minimal currency impact, driven by lower gross margin and
higher SG&A expenses.
Feminine Care (Tampons, Pads, and Liners)
Net sales decreased $8.5 million,
or 11.8% with minimal currency impact, largely driven by a decline
in Pads and to a lesser extent, Tampons, partly offset by growth in
Liners. Segment profit decreased $4.1
million, or 56.1%. Organic segment profit decreased
$3.9 million, or 53.4%, primarily
driven by lower sales and gross profit and was partially offset
lower SG&A expenses.
Full Fiscal Year 2025 Financial Outlook
The Company is providing the following outlook assumptions for
fiscal 2025*:
- Organic net sales are expected to be in the range of 1% to 3%
- Currency is now expected to negatively impact reported net
sales by 160-basis points (previously, 70-basis points
positive)
- GAAP EPS is now expected to be in the range of $2.54 to $2.74
(previously in the range of $2.59 to
$2.79)
- Includes: Restructuring and re-positioning charges**,
Sun Care reformulation, Other
costs.
- Adjusted EPS is now expected to be towards the lower end of the
range of $3.15 to $3.35, reflecting increased anticipated negative
foreign currency changes
- Includes an estimated $0.36 per
share unfavorable impact from foreign currency changes (previously
$0.18 per share unfavorable
impact)
- Adjusted gross margin is expected to increase approximately
55-basis points (previous 75-basis points), or 90-basis points
(unchanged) at constant currency
- Adjusted operating margin is expected to increase approximately
10 basis points (previously increase 40-basis points), or increase
50-basis points at constant currency
- The EPS outlook reflects the impact of expected share
repurchases of approximately $90
million
- Expect approximately 70% (previously two-thirds) of adjusted
net earnings to be generated in the 2nd half of the fiscal
year.
- Adjusted EBITDA is expected to be towards the lower end of in
the range of $356 to $368 million
- Includes an estimated $23 million
unfavorable (previously $11 million
unfavorable) impact from foreign currency changes
- Other Expense (Income), net is now expected to be income of
approximately $1 million (previously
expense of $7 million), inclusive of
interest income of $3 million
- Interest expense associated with debt is now expected to be
approximately $74 million (previously
$73 million)
- Adjusted effective tax rate is expected to be approximately
22%
- Total depreciation and amortization expense expected to be
approximately $89 million
- Capital expenditures expected to be approximately 2.5% to 3.0%
of net sales
- Free cash flow is expected to be approximately $185 million
* This outlook does not reflect potential impact from U.S. or
retaliatory tariffs given their rapidly evolving nature.
** In fiscal 2025, the Company is taking specific actions to
strengthen its operating model, simplify the organization and
improve manufacturing and supply chain efficiency through
restructuring and repositioning actions, including the
organizational and operational changes in Mexico. As a result of these actions, the
Company expects to incur pre-tax charges of approximately
$29 million for the full fiscal
year.
Webcast Information
In conjunction with this announcement, the Company will hold an
investor conference call beginning at 8:00
a.m. Eastern Time today. All interested parties may access a
live webcast of this conference call at www.edgewell.com, under the
"Investors," and "News and Events" tabs or by using the following
link: http://ir.edgewell.com/news-and-events/events
For those unable to participate during the live webcast, a
re-play will be available on www.edgewell.com under the
"Investors," "Financial Reports," and "Quarterly Earnings" tabs.
This release includes references to the Company's website and
references to additional information and materials found on its
website. The Company's website and such information and materials
are not incorporated by reference in, and are not part of, this
release.
About Edgewell
Edgewell is a leading pure-play consumer products company with
an attractive, diversified portfolio of established brand names
such as Schick®, Wilkinson Sword® and Billie® men's and women's
shaving systems and disposable razors; Edge and Skintimate® shave
preparations; Playtex®, Stayfree®, Carefree® and o.b.® feminine
care products; Banana Boat®, Hawaiian Tropic®, Bulldog®, Jack
Black®, and CREMO® sun and skin care products; and Wet Ones®
products. The Company has a broad global footprint and operates in
more than 50 markets, including the U.S., Canada, Mexico, Germany, Japan, the U.K. and Australia, with approximately 6,700
employees worldwide.
Forward-Looking Statements. This document contains
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934. You should not place undue reliance on these
statements. Forward-looking statements generally can be identified
by the use of words or phrases such as "believe," "expect,"
"expectation," "anticipate," "may," "could," "intend," "belief,"
"estimate," "plan," "target," "predict," "likely," "will,"
"should," "forecast," "outlook," or other similar words or phrases.
These statements are not based on historical facts, but instead
reflect the Company's expectations, estimates or projections
concerning future results or events, including, without limitation,
the future earnings and performance of Edgewell or any of its
businesses. Many factors outside our control could affect the
realization of these estimates. These statements are not guarantees
of performance and are inherently subject to known and unknown
risks, uncertainties and assumptions that are difficult to predict
and could cause the Company's actual results to differ materially
from those indicated by those statements. The Company cannot assure
you that any of its expectations, estimates or projections will be
achieved. The forward-looking statements included in this document
are only made as of the date of this document and the Company
disclaims any obligation to publicly update any forward-looking
statement to reflect subsequent events or circumstances, except as
required by law. You should not place undue reliance on these
statements.
In addition, other risks and uncertainties not presently known
to the Company or that it presently considers immaterial could
significantly affect the accuracy of any such forward-looking
statements. Risks and uncertainties include those detailed from
time to time in the Company's publicly filed documents, including
in Item 1A. Risk Factors of Part I of the Company's Annual Report
on Form 10-K filed with the Securities and Exchange Commission on
November 14, 2024.
Non-GAAP Financial Measures. While the Company reports
financial results in accordance with generally accepted accounting
principles ("GAAP") in the U.S., this discussion also includes
non-GAAP measures. These non-GAAP measures are referred to as
"adjusted" or "organic" and exclude items which are considered by
the Company as unusual or non-recurring and which may have a
disproportionate positive or negative impact on the Company's
financial results in any particular period. Reconciliations of
non-GAAP measures, including reconciliations of measures related to
the Company's fiscal 2025 financial outlook, are included within
the Notes to Condensed Consolidated Financial Statements included
with this release.
This non-GAAP information is provided as a supplement to, not as
a substitute for, or as superior to, measures of financial
performance prepared in accordance with GAAP. The Company uses this
non-GAAP information internally to make operating decisions and
believes it is helpful to investors because it allows more
meaningful period-to-period comparisons of ongoing operating
results. The information can also be used to perform analysis and
to better identify operating trends that may otherwise be masked or
distorted by the types of items that are excluded. This non-GAAP
information is a component in determining management's incentive
compensation. Finally, the Company believes this information
provides a higher degree of transparency. The following provides
additional detail on the Company's non-GAAP measures:
- The Company utilizes "adjusted" non-GAAP measures including
gross profit, SG&A, operating income, income taxes, net
earnings, diluted earnings per share, and EBITDA to internally make
operating decisions.
- Constant currency measures are calculated by removing the
impact of translational and transactional foreign currencies
changes, net of foreign currency hedges compared to the prior year.
Transactional foreign currency changes are driven by foreign legal
entities' transactions not denominated in local currency.
- The Company analyzes its net sales and segment profit on an
organic basis to better measure the comparability of results
between periods. Organic net sales and organic segment profit
exclude the impact of changes in foreign currency and the impact of
acquisitions.
- Segment profit will be impacted by fluctuations in translation
and transactional foreign currency. The impact of currency was
applied to segments using management's best estimate.
- Free cash flow is defined as net cash from operating
activities, less capital expenditures plus collections of deferred
purchase price of accounts receivable sold and proceeds from sales
of fixed assets. Free cash flow conversion is defined as free cash
flow as a percentage of net earnings adjusted for the net impact of
non-cash impairments.
- Net debt is defined as Gross debt less cash. Net debt leverage
ratio is defined as net debt less cash divided by trailing twelve
month adjusted EBITDA.
Basis of Presentation. Please refer to the Annual
Report on Form 10-K filed with the Securities and Exchange
Commission on November 14, 2024, as
amended by the Company on November 21,
2024.
EDGEWELL PERSONAL
CARE COMPANY
CONDENSED
CONSOLIDATED STATEMENTS OF EARNINGS
(unaudited, in
millions, except per share data)
|
|
Three Months
Ended
December
31,
|
|
2024
|
|
2023
|
Net sales
|
$
478.4
|
|
$
488.9
|
Cost of products
sold
|
286.8
|
|
291.2
|
Gross
profit
|
191.6
|
|
197.7
|
|
|
|
|
Selling, general and
administrative expense
|
102.9
|
|
103.3
|
Advertising and sales
promotion expense
|
50.3
|
|
48.2
|
Research and
development expense
|
13.9
|
|
13.3
|
Restructuring
charges
|
4.2
|
|
6.8
|
Operating
income
|
20.3
|
|
26.1
|
Interest expense
associated with debt
|
18.8
|
|
19.8
|
Other expense,
net
|
3.2
|
|
0.3
|
(Loss) earnings
before income taxes
|
(1.7)
|
|
6.0
|
Income tax
provision
|
0.4
|
|
1.2
|
Net (loss)
earnings
|
$
(2.1)
|
|
$
4.8
|
|
|
|
|
(Loss) earnings per
share:
|
|
|
|
Basic net (loss) earnings per share
|
$
(0.04)
|
|
$
0.10
|
Diluted net (loss) earnings per share
|
$
(0.04)
|
|
$
0.09
|
|
|
|
|
Weighted-average
shares outstanding:
|
|
|
|
Basic
|
48.7
|
|
50.1
|
Diluted
|
48.7
|
|
50.5
|
EDGEWELL PERSONAL
CARE COMPANY
CONDENSED
CONSOLIDATED BALANCE SHEETS
(unaudited, in
millions)
|
|
December 31,
2024
|
|
September
30,
2024
|
Assets
|
|
|
|
Current
assets
|
|
|
|
Cash and cash
equivalents
|
$
175.5
|
|
$
209.1
|
Trade receivables,
less allowance for doubtful accounts
|
120.5
|
|
109.4
|
Inventories
|
501.6
|
|
477.3
|
Other current
assets
|
147.6
|
|
140.2
|
Total current
assets
|
945.2
|
|
936.0
|
Property, plant and
equipment, net
|
342.7
|
|
349.1
|
Goodwill
|
1,328.7
|
|
1,338.6
|
Other intangible
assets, net
|
934.3
|
|
948.5
|
Other assets
|
151.5
|
|
158.7
|
Total
assets
|
$
3,702.4
|
|
$
3,730.9
|
|
|
|
|
Liabilities and
Shareholders' Equity
|
|
|
|
Current
liabilities
|
|
|
|
Notes
payable
|
$
27.2
|
|
$
24.5
|
Accounts
payable
|
203.8
|
|
219.3
|
Other current
liabilities
|
228.0
|
|
319.8
|
Total current
liabilities
|
459.0
|
|
563.6
|
Long-term
debt
|
1,440.6
|
|
1,275.0
|
Deferred income tax
liabilities
|
132.6
|
|
133.2
|
Other
liabilities
|
169.2
|
|
175.0
|
Total
liabilities
|
2,201.4
|
|
2,146.8
|
Shareholders'
equity
|
|
|
|
Common
shares
|
0.7
|
|
0.7
|
Additional paid-in
capital
|
1,561.8
|
|
1,586.0
|
Retained
earnings
|
1,080.9
|
|
1,090.1
|
Common shares in
treasury at cost
|
(944.7)
|
|
(937.9)
|
Accumulated other
comprehensive loss
|
(197.7)
|
|
(154.8)
|
Total shareholders'
equity
|
1,501.0
|
|
1,584.1
|
Total liabilities
and shareholders' equity
|
$
3,702.4
|
|
$
3,730.9
|
EDGEWELL PERSONAL
CARE COMPANY
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited, in
millions)
|
|
Three Months
Ended
December 31,
|
|
2024
|
|
2023
|
Cash Flow from
Operating Activities
|
|
|
|
Net (loss)
earnings
|
$
(2.1)
|
|
$
4.8
|
Depreciation and
amortization
|
21.7
|
|
22.5
|
Share-based
compensation expense
|
6.1
|
|
7.0
|
Loss on sale of
assets
|
1.4
|
|
0.1
|
Deferred compensation
payments
|
(0.2)
|
|
(0.4)
|
Deferred income
taxes
|
0.2
|
|
(0.2)
|
Other, net
|
2.3
|
|
(0.6)
|
Changes in current
assets and liabilities used in operations
|
(145.0)
|
|
(106.1)
|
Net cash used for
operating activities
|
$
(115.6)
|
|
$
(72.9)
|
|
|
|
|
Cash Flow from
Investing Activities
|
|
|
|
Capital
expenditures
|
$
(16.8)
|
|
$
(6.5)
|
Collection of deferred
purchase price on accounts receivable sold
|
1.1
|
|
—
|
Other, net
|
—
|
|
0.5
|
Net cash used for
investing activities
|
$
(15.7)
|
|
$
(6.0)
|
|
|
|
|
Cash Flow from
Financing Activities
|
|
|
|
Cash proceeds from
debt with original maturities greater than 90 days
|
$
369.0
|
|
$
216.0
|
Cash payments on debt
with original maturities greater than 90 days
|
(204.0)
|
|
(125.0)
|
Proceeds from debt
with original maturities of 90 days or less
|
3.7
|
|
4.1
|
Repurchase of
shares
|
(30.3)
|
|
(15.0)
|
Dividends to common
shareholders
|
(7.9)
|
|
(7.6)
|
Net financing
(outflow) inflow from the Accounts Receivable Facility
|
(13.3)
|
|
4.8
|
Employee shares
withheld for taxes
|
(7.3)
|
|
(7.0)
|
Other, net
|
—
|
|
(0.5)
|
Net cash provided by
financing activities
|
$
109.9
|
|
$
69.8
|
|
|
|
|
Effect of exchange rate
changes on cash
|
(12.2)
|
|
6.9
|
|
|
|
|
Net decrease in cash
and cash equivalents
|
(33.6)
|
|
(2.2)
|
Cash and cash
equivalents, beginning of period
|
209.1
|
|
216.4
|
Cash and cash
equivalents, end of period
|
$
175.5
|
|
$
214.2
|
EDGEWELL PERSONAL CARE COMPANY
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited,
in millions, except per share data)
Note 1 — Segments
The Company conducts its business in the following three
segments: Wet Shave, Sun and Skin Care, and Feminine Care
(collectively, the "Segments," and each individually, a "Segment").
Segment performance is evaluated based on segment profit, exclusive
of general corporate expenses, share-based compensation costs,
items which are considered by the Company to be unusual or
non-recurring and which may have a disproportionate positive or
negative impact on the Company's financial results in any
particular period and the amortization of intangible assets.
Financial items, such as interest income and expense, are managed
on a global basis at the corporate level. The exclusion of such
charges from segment results reflects management's view on how it
evaluates segment performance.
Segment net sales and profitability are presented below:
|
Three Months
Ended
December 31,
|
|
2024
|
|
2023
|
Net
Sales
|
|
|
|
Wet Shave
|
$
294.5
|
|
$
301.7
|
Sun and Skin
Care
|
120.6
|
|
115.4
|
Feminine
Care
|
63.3
|
|
71.8
|
Total net
sales
|
$
478.4
|
|
$
488.9
|
|
|
|
|
Segment
Profit
|
|
|
|
Wet Shave
|
$
46.6
|
|
$
53.7
|
Sun and Skin
Care
|
(3.4)
|
|
(1.3)
|
Feminine
Care
|
3.2
|
|
7.3
|
Total segment
profit
|
46.4
|
|
59.7
|
General corporate and
other expenses
|
(11.6)
|
|
(16.2)
|
Amortization of
intangibles
|
(7.8)
|
|
(7.8)
|
Interest and other
expense, net
|
(21.1)
|
|
(20.1)
|
Restructuring and
repositioning expenses
|
(4.2)
|
|
(6.8)
|
Acquisition and
integration costs
|
(0.5)
|
|
(0.7)
|
Sun Care reformulation
costs
|
(1.0)
|
|
(0.5)
|
Wet Ones manufacturing
plant fire
|
—
|
|
(1.5)
|
Gain on
investment
|
0.9
|
|
—
|
Other project and
related costs
|
(2.8)
|
|
(0.1)
|
Total (loss)
earnings before income taxes
|
$
(1.7)
|
|
$
6.0
|
Refer to Note 2 - GAAP to Non-GAAP Reconciliations for the
income statement location of non-GAAP adjustments to (loss)
earnings before income taxes.
Note 2 — GAAP to Non-GAAP Reconciliations
The following tables provide a GAAP to Non-GAAP reconciliation
of certain line items from the Condensed Consolidated Statement of
Earnings:
|
Three Months Ended
December 31, 2024
|
|
Gross
Profit
|
|
SG&A
|
|
Operating
Income
|
|
EBIT (1)
|
|
Income
taxes
|
|
Net (Loss)
Earnings
|
|
Diluted
EPS
|
GAAP —
Reported
|
$ 191.6
|
|
$ 102.9
|
|
$ 20.3
|
|
$
(1.7)
|
|
$
0.4
|
|
$
(2.1)
|
|
$
(0.04)
|
Restructuring and
repositioning expenses
|
—
|
|
—
|
|
4.2
|
|
4.2
|
|
1.0
|
|
3.2
|
|
0.07
|
Acquisition and
integration costs
|
—
|
|
0.5
|
|
0.5
|
|
0.5
|
|
0.1
|
|
0.4
|
|
0.01
|
Sun Care reformulation
costs
|
—
|
|
—
|
|
1.0
|
|
1.0
|
|
0.3
|
|
0.7
|
|
0.01
|
Gain on
investment
|
—
|
|
—
|
|
—
|
|
(0.9)
|
|
—
|
|
(0.9)
|
|
(0.02)
|
Other project and
related costs
|
—
|
|
1.0
|
|
1.0
|
|
2.8
|
|
0.8
|
|
2.0
|
|
0.04
|
Total Adjusted
Non-GAAP
|
$ 191.6
|
|
$ 101.4
|
|
$ 27.0
|
|
$
5.9
|
|
$
2.6
|
|
$
3.3
|
|
$
0.07
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted Non-GAAP
Constant Currency
|
|
$
0.24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP as a percent of
net sales
|
40.1 %
|
|
21.5 %
|
|
4.2 %
|
|
GAAP effective tax
rate
|
(21.7) %
|
|
|
Adjusted as a percent
of net sales
|
40.1 %
|
|
21.2 %
|
|
5.6 %
|
|
Adjusted effective tax
rate
|
43.6 %
|
|
|
Adjusted Constant
Currency as a percent of net sales
|
41.5 %
|
|
|
|
7.2 %
|
|
|
|
|
|
|
|
|
|
Three Months Ended
December 31, 2023
|
|
Gross
Profit
|
|
SG&A
|
|
Operating
Income
|
|
EBIT (1)
|
|
Income
taxes
|
|
Net
Earnings
|
|
Diluted
EPS
|
GAAP —
Reported
|
$ 197.7
|
|
$ 103.3
|
|
$ 26.1
|
|
$
6.0
|
|
$
1.2
|
|
$
4.8
|
|
$
0.09
|
Restructuring and
repositioning expenses
|
—
|
|
—
|
|
6.8
|
|
6.8
|
|
1.7
|
|
5.1
|
|
0.11
|
Acquisition and
integration costs
|
—
|
|
0.7
|
|
0.7
|
|
0.7
|
|
0.2
|
|
0.5
|
|
0.01
|
Sun Care reformulation
costs
|
—
|
|
—
|
|
0.5
|
|
0.5
|
|
0.1
|
|
0.4
|
|
0.01
|
Wet Ones manufacturing
plant fire
|
1.5
|
|
—
|
|
1.5
|
|
1.5
|
|
0.4
|
|
1.1
|
|
0.02
|
Other project and
related costs
|
—
|
|
0.1
|
|
0.1
|
|
0.1
|
|
—
|
|
0.1
|
|
—
|
Total Adjusted
Non-GAAP
|
$ 199.2
|
|
$ 102.5
|
|
$ 35.7
|
|
$
15.6
|
|
$
3.6
|
|
$ 12.0
|
|
$
0.24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP as a percent of
net sales
|
40.4 %
|
|
21.1 %
|
|
5.3 %
|
|
GAAP effective tax
rate
|
20.1 %
|
|
|
Adjusted as a percent
of net sales
|
40.7 %
|
|
21.0 %
|
|
7.3 %
|
|
Adjusted effective tax
rate
|
22.8 %
|
|
|
(1) EBIT is defined as
Earnings before Income taxes.
|
Note 3 - Net Sales and Profit by Segment
Operations for the Company are reported via three Segments. The
following tables present changes in net sales and segment profit
for the three months ended December 31, 2024, as compared
to the corresponding period in the prior year quarter.
Net
Sales
|
Quarter ended
December 31, 2024
|
|
Wet
Shave
|
|
Sun and
Skin
Care
|
|
Feminine
Care
|
|
Total
|
Net Sales - Q1
2024
|
$
301.7
|
|
|
|
$
115.4
|
|
|
|
$ 71.8
|
|
|
|
$
488.9
|
|
|
Organic
|
(4.0)
|
|
(1.3) %
|
|
5.9
|
|
5.1 %
|
|
(8.4)
|
|
(11.7) %
|
|
(6.5)
|
|
(1.3) %
|
Impact of
currency
|
(3.2)
|
|
(1.1) %
|
|
(0.7)
|
|
(0.6) %
|
|
(0.1)
|
|
(0.1) %
|
|
(4.0)
|
|
(0.8) %
|
Net Sales - Q1
2025
|
$
294.5
|
|
(2.4) %
|
|
$
120.6
|
|
4.5 %
|
|
$ 63.3
|
|
(11.8) %
|
|
$
478.4
|
|
(2.1) %
|
Segment
Profit
|
Quarter Ended
December 31, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Wet
Shave
|
|
Sun and
Skin
Care
|
|
Feminine
Care
|
|
Total
|
Segment Profit (Loss) -
Q1 2024
|
$ 53.7
|
|
|
|
$ (1.3)
|
|
|
|
$ 7.3
|
|
|
|
$ 59.7
|
|
|
Organic
|
(0.2)
|
|
(0.4) %
|
|
(1.4)
|
|
107.7 %
|
|
(3.9)
|
|
(53.4) %
|
|
(5.5)
|
|
(9.2) %
|
Impact of
currency
|
(6.9)
|
|
(12.8) %
|
|
(0.7)
|
|
53.8 %
|
|
(0.2)
|
|
(2.7) %
|
|
(7.8)
|
|
(13.1) %
|
Segment Profit (Loss) -
Q1 2025
|
$ 46.6
|
|
(13.2) %
|
|
$ (3.4)
|
|
161.5 %
|
|
$ 3.2
|
|
(56.1) %
|
|
$ 46.4
|
|
(22.3) %
|
For all tables, the impact of currency to segment profit
includes both the translational and transactional currency changes
during the quarter.
Note 4 - Net Debt and EBITDA
The Company reports financial results on a GAAP and adjusted
basis. The tables below are used to reconcile Net Debt and Net
(loss) earnings to EBITDA and Adjusted EBITDA, which are non-GAAP
measures, to improve comparability of results between periods.
|
December 31,
2024
|
|
September
30,
2024
|
Notes
payable
|
$
27.2
|
|
$
24.5
|
Long-term
debt
|
1,440.6
|
|
1,275.0
|
Gross debt
|
$
1,467.8
|
|
$
1,299.5
|
Less: Cash and cash
equivalents
|
175.5
|
|
209.1
|
Net debt
|
$
1,292.3
|
|
$
1,090.4
|
|
Three Months
Ended
December
31,
|
|
2024
|
|
2023
|
Net (loss)
earnings
|
$
(2.1)
|
|
$
4.8
|
Income tax
provision
|
0.4
|
|
1.2
|
Interest expense,
net
|
18.3
|
|
19.1
|
Depreciation and
amortization
|
21.7
|
|
22.5
|
EBITDA
|
$
38.3
|
|
$
47.6
|
|
|
|
|
Restructuring and
repositioning expenses
|
4.2
|
|
6.8
|
Acquisition and
integration costs
|
0.5
|
|
0.7
|
Sun Care reformulation
costs
|
1.0
|
|
0.5
|
Wet Ones manufacturing
plant fire
|
—
|
|
1.5
|
Gain on
investment
|
(0.9)
|
|
—
|
Other project and
related costs
|
2.8
|
|
0.1
|
Adjusted
EBITDA
|
$
45.9
|
|
$
57.2
|
|
|
|
|
Adjusted EBITDA
Constant Currency
|
$
57.1
|
|
|
Note 5 - Outlook
The following tables provide reconciliations of Adjusted EPS and
Adjusted EBITDA, Non-GAAP measures, included within the Company's
outlook for projected fiscal 2025 results:
Adjusted EPS
Outlook
|
|
|
Fiscal 2025 GAAP
EPS
|
approx.
|
$2.54 -
$2.74
|
|
|
|
Restructuring and
repositioning costs
|
approx.
|
0.61
|
Sun Care reformulation
costs
|
approx.
|
0.11
|
Other costs
|
approx.
|
0.11
|
Income
taxes(1)
|
approx.
|
(0.22)
|
|
|
|
Fiscal 2025 Adjusted
EPS Outlook (Non-GAAP)
|
approx.
|
$3.15 -
$3.35
|
(1) Income tax effect
of the adjustments to Fiscal 2025 GAAP EPS noted
above.
|
Adjusted EBITDA
Outlook
|
|
|
Fiscal 2025 GAAP Net
Income
|
approx.
|
$123 - $133
|
Income tax
provision
|
approx.
|
34
|
Interest expense,
net
|
approx.
|
71
|
Depreciation and
amortization
|
approx.
|
89
|
EBITDA
|
approx.
|
$316 - $328
|
|
|
|
Restructuring and
repositioning costs
|
approx.
|
29
|
Sun Care reformulation
costs
|
approx.
|
5
|
Other costs
|
approx.
|
6
|
Fiscal 2025 Adjusted
EBITDA
|
approx.
|
$356 - $368
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/edgewell-personal-care-announces-first-quarter-fiscal-2025-results-302371932.html
SOURCE Edgewell Personal Care Company